BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
282 hedge funds and large institutions have $8.37B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2021 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 109 increasing their positions, 82 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
6% less call options, than puts
Call options by funds: $131M | Put options by funds: $139M
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
Holders
282
Holding in Top 10
12
Calls
$131M
Puts
$139M
Top Buyers
| 1 | +$93.9M | |
| 2 | +$88.4M | |
| 3 | +$48.1M | |
| 4 |
EP
Eversept Partners
New York
|
+$43.4M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$42.7M |
Top Sellers
| 1 | -$231M | |
| 2 | -$60.9M | |
| 3 | -$49.5M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$33.2M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$25.4M |